Advent Pharma Ltd. (DSE:ADVENT)
Bangladesh
· Delayed Price · Currency is BDT 12.90
-0.30 (-2.27%)
At close: Mar 8, 2026
Advent Pharma Ratios and Metrics
Market cap in millions BDT. Fiscal year is July - June.
Millions BDT. Fiscal year is Jul - Jun.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 6, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 | 2020 - 2016 |
| Market Capitalization | 1,211 | 1,267 | 2,384 | 2,459 | 2,338 | 2,274 | Upgrade
|
| Market Cap Growth | -16.67% | -46.88% | -3.03% | 5.18% | 2.82% | 20.13% | Upgrade
|
| Enterprise Value | 1,283 | 1,338 | 2,456 | 2,530 | 2,392 | 2,285 | Upgrade
|
| Last Close Price | 13.00 | 13.55 | 25.34 | 25.90 | 24.41 | 23.56 | Upgrade
|
| PE Ratio | 21.02 | 18.94 | 28.39 | 24.93 | 23.97 | 20.02 | Upgrade
|
| PS Ratio | 2.34 | 2.53 | 4.17 | 4.41 | 4.41 | 4.51 | Upgrade
|
| PB Ratio | 0.78 | 0.83 | 1.62 | 1.76 | 1.78 | 1.84 | Upgrade
|
| P/TBV Ratio | 0.78 | 0.83 | 1.62 | 1.76 | 1.78 | 1.84 | Upgrade
|
| P/FCF Ratio | 138.67 | 61.59 | 182.32 | 958.68 | - | - | Upgrade
|
| P/OCF Ratio | 17.74 | 11.04 | 13.61 | 11.98 | 13.02 | 12.60 | Upgrade
|
| EV/Sales Ratio | 2.48 | 2.67 | 4.30 | 4.53 | 4.51 | 4.54 | Upgrade
|
| EV/EBITDA Ratio | 8.85 | 8.46 | 11.83 | 13.05 | 13.66 | 13.09 | Upgrade
|
| EV/EBIT Ratio | 15.46 | 13.99 | 17.34 | 18.69 | 17.93 | 16.75 | Upgrade
|
| EV/FCF Ratio | 146.95 | 65.04 | 187.80 | 986.61 | - | - | Upgrade
|
| Debt / Equity Ratio | 0.05 | 0.05 | 0.05 | 0.05 | 0.05 | 0.05 | Upgrade
|
| Debt / EBITDA Ratio | 0.52 | 0.48 | 0.37 | 0.37 | 0.36 | 0.34 | Upgrade
|
| Debt / FCF Ratio | 8.68 | 3.69 | 5.81 | 27.92 | - | - | Upgrade
|
| Net Debt / Equity Ratio | 0.05 | 0.05 | 0.05 | 0.05 | 0.05 | 0.01 | Upgrade
|
| Net Debt / EBITDA Ratio | 0.50 | 0.47 | 0.35 | 0.36 | 0.34 | 0.10 | Upgrade
|
| Net Debt / FCF Ratio | 8.29 | 3.60 | 5.51 | 27.50 | -5.16 | -4.69 | Upgrade
|
| Asset Turnover | 0.27 | 0.26 | 0.31 | 0.33 | 0.34 | 0.35 | Upgrade
|
| Inventory Turnover | 5.41 | 4.87 | 4.68 | 4.16 | 3.96 | 4.01 | Upgrade
|
| Quick Ratio | 1.22 | 1.01 | 0.78 | 0.62 | 0.71 | 1.03 | Upgrade
|
| Current Ratio | 1.70 | 1.51 | 1.28 | 1.15 | 1.38 | 1.72 | Upgrade
|
| Return on Equity (ROE) | 3.76% | 4.46% | 5.85% | 7.27% | 7.66% | 9.65% | Upgrade
|
| Return on Assets (ROA) | 2.69% | 3.15% | 4.86% | 4.93% | 5.27% | 5.90% | Upgrade
|
| Return on Invested Capital (ROIC) | 3.97% | 4.71% | 7.61% | 7.30% | 7.61% | 9.73% | Upgrade
|
| Return on Capital Employed (ROCE) | 4.70% | 5.50% | 8.50% | 8.60% | 9.00% | 10.00% | Upgrade
|
| Earnings Yield | 4.73% | 5.28% | 3.52% | 4.01% | 4.17% | 5.00% | Upgrade
|
| FCF Yield | 0.72% | 1.62% | 0.55% | 0.10% | -0.49% | -0.16% | Upgrade
|
| Dividend Yield | 0.39% | 0.37% | 0.40% | 0.77% | 0.82% | 0.83% | Upgrade
|
| Payout Ratio | 7.57% | 22.06% | 9.76% | 8.93% | 22.79% | 7.11% | Upgrade
|
| Buyback Yield / Dilution | 0.63% | - | - | - | - | - | Upgrade
|
| Total Shareholder Return | 1.01% | 0.37% | 0.40% | 0.77% | 0.82% | 0.83% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.